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ABSTRACT
Objectives: To evaluate the prevalence and clinical
presentation of myocardial infarction (MI) and
myocarditis in young adults presenting with chest
pain (CP) and an elevated serum troponin I (TnI) to the
emergency department (ED).
Design: Retrospective, observational, single-centre
study.
Participants: All consecutive patients 18–40 years old
admitted to the ED for CP with an elevated TnI
concentration.
Primary outcome measures: Prevalence of MI,
myocarditis and the characterisation of clinical
presentation.
Results: 1588 patients between 18 and 40 years old
were admitted to the ED with CP during 30
consecutive months. 49 (3.1%) patients with an
elevated TnI (>0.09 μg/l) were included. 32.7% (16/49)
were diagnosed with MI (11 ST-elevation myocardial
infarction (STEMI) and 5 non-ST-elevation myocardial
infarction (NSTEMI)) and 59.2% (29/49) with
myocarditis. Compared with patients with myocarditis,
MI patients were older (34.1±3.8 vs 26.9±6.4,
p=0.0002) with more cardiovascular risk factors
(mean 2.06 vs 0.69). Diabetes (18.8% vs 0%,
p=0.0039), dyslipidaemia (56.2% vs 3.4%, p<0.0001)
and family history of coronary artery disease (CAD)
(37.5% vs 10.3% p=0.050) were associated with MI.
Fever or recent viral illness were present in 75.9%
(22/29) of patients with myocarditis, and in 0% of MI
patients (p<0.0001). During follow-up, two patients
with myocarditis were re-admitted for CP.
Conclusions: In this study, 32.7% of patients
<40-year-old admitted to an ED with CP and elevated
TnI had a diagnosis of MI. Key distinctive clinical
factors include diabetes, dyslipidaemia, family history
of CAD and fever or recent viral illness.
INTRODUCTION
Chest pain (CP) represents about 5% of
admissions to emergency departments (ED),
even in young adults.1 Myocardial infarction
(MI) and myocarditis are among the most
important cardiac diagnoses to consider in
patients with CP and elevated cardiac bio-
markers. Clinical and ECG ﬁndings are not
speciﬁc for either condition and separating
both diagnoses is often a challenge.
The requirement for and timing of coron-
ary angiography is a recurrent question in
young patients who usually present with
fewer coronary risk factors, and therefore a
lower pretest probability of MI than older
patients. Only a few small epidemiological
studies have been published in this speciﬁc
age group.2–5 A recent prospective cohort
study of 28 778 patients with acute coronary
syndrome (ACS) found that 195 patients
(0.7%) were 35 years old or younger.6 The
global cardiovascular risk in this population
tends to be underestimated.7 Smoking,
ARTICLE SUMMARY
Article focus
▪ Myocardial infarction (MI) in young adults has
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data are available.
▪ Differentiating between MI and myocarditis is a
difficult diagnostic challenge.
Key messages
▪ MI is found in approximately one-third of patients
<40 years old admitted to the emergency depart-
ment with chest pain (CP) and elevated serum
cardiac TnI concentration. The possibility of MI
should not be overlooked in young adults.
▪ Key clinical features may help differentiate MI
from myocarditis.
Strengths and limitations of this study
▪ This study provides an estimate of the preva-
lence of MI in young adults admitted with CP to
a single centre.
▪ This study demonstrates the usefulness of clin-
ical features in differentiating MI from myocardi-
tis and the role of early cardiac MRI.
▪ Limitations of this study include the relatively
small number of patients and the retrospective
design.
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dyslipidaemia and a family history of coronary artery
disease (CAD) are considered as the most important risk
factors for ischaemic heart disease.2–6 8
Myocarditis may be associated with serious morbidity
such as dilated cardiomyopathy with heart failure and
sudden cardiac death.9–11 Myocarditis is a difﬁcult diag-
nosis due to the lack of speciﬁcity of history, clinical signs,
ECG changes and biomarker elevation. Endomyocardial
biopsy (EMB) remains the gold standard for a deﬁnite
diagnosis, but it is only recommended in speciﬁc circum-
stances and therefore is not widely used in clinical prac-
tice.12 Moreover, EMB still has a suboptimal sensitivity
due to sampling error and remains an invasive procedure
with potentially severe complications.12–14 Recently,
cardiac MR (CMR) has emerged as a very promising
technique to diagnose myocarditis in patients presenting
with CP.15 16 It is the only non-invasive, radiation-free
technique capable of positively showing the myocardial
damage of acute myocarditis. A recent consensus paper
recommends its use for diagnosing myocarditis.17
Our study aimed to evaluate the prevalence of MI and
myocarditis in patients younger than 40 years old
presenting to the ED with CP and an elevated serum
troponin I (TnI) concentration. In addition, we sought
to establish the differences in clinical, angiographic and
CMR features between MI and myocarditis in this
cohort.
METHODS
All patients between 18 and 40 years of age admitted with
CP and elevated cardiac biomarkers (TnI>0.09 μg/l,
Beckman Coulter, Krefeld, Germany) to the ED of the
University Hospital of Lausanne (Switzerland) between
January 2009 and June 2011 were retrospectively ana-
lysed. TnI>0.09 μg/l represents the 99th percentile refer-
ence (with 10% CV). High-sensitive troponin assays have
not been used in this study.18 Forty years of age was
chosen as a cut-off because only a few studies have been
published in this speciﬁc age group. All data were col-
lected from patients’ clinical notes and electronic
records. We analysed all cardiovascular risk factors
(hypertension (>140/90), current smoking, diabetes
(fasting glucose >7 mmol/l or HbA1c >6.5%), dyslipidae-
mia (total cholesterol >5 mmol/l or low-density lipopro-
tein >3 mmol/l), family history of CAD as recently
deﬁned,19 and obesity with body mass index >30 kg/m2).
All ECGs, TnI measurements, echocardiography, coron-
ary angiograms and CMR images were reviewed. Body
temperature at admission, history of fever or of recent
viral illness (<2 weeks) and cocaine abuse were noted. All
medications on discharge were reviewed. Patients were
classiﬁed into three groups, according to their ﬁnal diag-
nosis. Group 1: Patients diagnosed with MI (ST-elevation
myocardial infarction (STEMI) or non-ST-elevation myo-
cardial infarction (NSTEMI)) based on clinical presenta-
tion, ECG, and the presence of a culprit lesion on the
coronary angiogram, according to current guidelines.20
Group 2: Patients diagnosed with myocarditis based on at
least one of three criteria: (1) presence of typical subepi-
cardial late gadolinium enhancement (LGE) on CMR,
(2) TnI elevation with normal coronary angiogram and
no evidence of an alternative diagnosis and (3) clinical
diagnosis in the case of typical pericarditic CP, ECG sug-
gestive of pericarditis, elevated troponin and no evidence
of an alternative diagnosis. Group 3: Patients with a diag-
nosis other than MI or myocarditis.
All the data were analysed by two independent cardiol-
ogists. Clinical follow-up was conducted by phone.
Patients and/or their general practitioners were con-
tacted to assess all cause mortality, MI20 and rehospitali-
sation for CP. This study was approved by the local ethics
committee.
Statistics
All analyses were performed with GraphPad Prism soft-
ware, V.5.04 (GraphPad Software, La Jolla, California,
USA). Statistics are reported as mean and SD, median
and IQR or counts (%). Continuous variables were com-
pared with unpaired t tests, and categorical variables
with the Fisher’s exact or χ² tests, as appropriate.
RESULTS
Patient’s clinical characteristics and prevalence
From January 2009 to June 2011, 51 153 patients aged
18–40 years were admitted to our ED; 1588 patients
(3.1% of all admissions, 57.9% men) were admitted for
CP. In total, 505 patients had a TnI measured (31.8%)
and 49 (3.1% of all patient with CP) had an elevated
serum TnI concentration. These 49 patients were
included for further analysis (ﬁgure 1). Baseline charac-
teristics are summarised in table 1.
Mean age was 29.6±6.4 years old and most patients
were men (n=43, 87.7%). Group 1 included 32.7% of
patients (16/49) diagnosed with MI. Eleven were STEMI
(69%) and ﬁve were NSTEMI (31%). Group 1 repre-
sents 1% of all admissions for CP (16/1588). All
16 patients had coronary angiograms demonstrating a
culprit coronary lesion. In patients with STEMI, seven
had an occlusion of the left anterior descending artery
(LAD), three of right coronary artery (RCA) and one of
the left circumﬂex artery. Two STEMI were related to a
spontaneous coronary dissection, one in a young man
and one in a postpartum woman. Group 2 included
59.2% of patients (29/49) who were diagnosed with
myocarditis. Seventeen diagnoses were conﬁrmed by
CMR with the presence of typical subepicardial LGE. In
these patients, six also had a normal coronary angio-
gram. Among the 12 other patients, 3 had a normal cor-
onary angiogram; 3 had no signs of ischaemia on CMR
and no typical LGE (considered as inconclusive CMR
for myocarditis) and 6 had no complementary work-up
and were diagnosed on clinical presentation only. No
evidence of an alternative diagnosis was found in any
patient. Only one patient in group two had an EMB.
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Group 3 includes four patients with CP and elevated TnI
attributable to other diagnoses corresponding to 8.2%
(4/49). In this group, one patient with corrected trans-
position of the great arteries presented with right ven-
tricular dysfunction. One patient with severe left heart
failure presented with a supraventricular arrhythmia and
received three inappropriate shocks by his internal car-
dioverter deﬁbrilator (ICD). One patient had a hyper-
tensive crisis after intravenous injection of adrenalin for
an anaphylactic shock and one was diagnosed with a
type A aortic dissection.
Differences in clinical, angiographic and CMR features
between MI and myocarditis
Patients with MI (group 1) were signiﬁcantly older than
myocarditis patients (group 2) (mean age 34.1±3.9 vs
26.9±6.4, p=0.0002). Only two MI (1 STEMI, 1 NSTEMI)
occurred in patients younger than 30 years old.
Compared with patients with myocarditis, MI patients
had more cardiovascular risk factors (mean 2.06 vs
0.69). Diabetes (18.8% vs 0%, p=0.0039), dyslipidaemia
(56.2% vs 3.4, p<0.0001) and family history of CAD
(37.5% vs 10.3 p=0.050) were more associated with MI,
compared with myocarditis, respectively. No signiﬁcant
association was found for smoking, hypertension and
obesity. Smoking was highly prevalent in the cohort,
both in MI (56.2%) and in myocarditis patients (41.4%;
p=0.37). Fever on admission (>38°C) or history of recent
(<2 weeks) viral illness was present in 75.9% (22/29) of
patients with myocarditis, and in 0% of MI patients
(p<0.0001; table 1). No cocaine abuse was reported by
any patients included in this study.
All the CMR and coronary angiograms performed in
the study are summarised in table 1. All patients included
in the study underwent echocardiography. No statistically
signiﬁcant differences were found in left ventricular
ejection fraction (LVEF) between both groups (mean±SD
LVEF 51±7.5 in group 1, 52.7±8.2 in group 2; p=0.48). In
12/14 patients with MI (85.7%) and in 8/29 of patients
with myocarditis (27.6%), a segmental abnormality was
found (p=0.0042). A CMR study was performed in 20
patients with myocarditis (median time after admission:
3.5 days, IQR 2–5 days). In comparison, 14/16 coronary
angiograms were performed on the day of admission and
2/16 on day 1 after admission in patients with MI.
Typical subepicardial LGE was found in the majority of
patients with myocarditis (17/20, 85%). In three patients,
CMR demonstrated no LGE at all and no perfusion defect
was detected after adenosine stress. In these patients,
admission/peak TnI (μg/l) elevation was 0.44/1.29, 0.11/
0.14 and 1.4/1.4 μg/l, peak CK activity (Ui/l) was 200, 233
and 319 and CMR scan was performed 5, 3 and 8 days after
symptom onset, respectively. All three patients had a pre-
served ejection fraction. The absence of subepicardial LGE
on CMR despite a clinical presentation that was typical for
myocarditis was interpreted as a very small focus of myocar-
ditis, below the threshold of LGE detection.
All the patients with MI were treated according
to current guidelines with aspirin, clopidogrel, statins,
ACE inhibitors and β-blockers.21 The discharge
Figure 1 Study flow chart.
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treatment of patients diagnosed with myocarditis was
much more heterogeneous. Only a minority (9) were
prescribed ACE-inhibitors and β-blockers.
During follow-up (mean 19.9 months±8.6), only two
patients from group 2 were re-admitted for CP but had no
TnI elevation. No patient from group 1 was readmitted.
There was no death or MI during the follow-up period.
DISCUSSION
Identiﬁcation of the aetiology of CP with elevated
cardiac biomarkers in young patients is a frequent and
challenging issue in the ED. The clinical presentation of
myocarditis can mimic MI, and neither symptoms nor
ECG changes are speciﬁc for this condition. In our
series MI occurs in about 1% of all admissions in patient
<40 years with CP and reaches 32.7% when CP is asso-
ciated with elevated TnI.
Based on our study, key clinical features may help to
differentiate MI from myocarditis. Patients with MI are
signiﬁcantly older and have more cardiovascular risk
factors. Diabetes, dyslipidaemia and family history of
CAD were signiﬁcantly associated with MI. Current
smoking showed no signiﬁcant association with MI, pos-
sibly due to the high prevalence of smoking in all
groups of our study. The prevalence of cardiovascular
risk factors in our cohort is in keeping with a recently
published prospective cohort of young patients present-
ing with ACS.6 In our cohort, STEMI was more frequent
than NSTEMI among MI patients, and the LAD was the
most frequent culprit artery, which is also in accordance
with previous observations.22–25 Fever (>38°C) or a
history of recent viral illness favoured myocarditis since
the symptoms were present in three-quarters of patients
with myocarditis, and in none of the patients with MI.
In patients presenting with CP, the ﬁrst goal is to rule
out ongoing MI before considering a diagnosis of myo-
carditis. In this regard, coronary angiography is most
commonly the ﬁrst exam performed. Coronary angiog-
raphy is often more easily and quickly available in emer-
gency settings than CMR, as demonstrated in our results.
Nevertheless, CMR offers the possibility to non-invasively
conﬁrm the suspected diagnosis by demonstrating a
typical ‘myocarditic’ subepicardial pattern of LGE.
Although not yet mandatory in international recommen-
dations, in the future CMR will probably have an import-
ant place in the diagnosis of myocarditis, and is already
strongly recommended by some scientiﬁc societies.17
Its use in the acute setting in stable patients is also very
promising.
Table 1 Demographic data and characteristics of patients
All patients included
Number of patients 49
Males 43 (87.7%)
Age (mean±SD) 29.6±6.4
Group 1 myocardial
infarction
Group 2 myocarditis Group 3 other
diagnosis
p Value
group 1 vs 2
Patients 16 (32.7) 29 (59.2) 4
Males 12 (75) 24 (82.8) 2
Age (mean±SD) 34±3.8 26.9±6.4 32±5.2 0.0002
Hypertension 2 (12.5) 0 0 0.12
Diabetes 3 (18.8) 0 0 0.0039
Dyslipidaemia 9 (56.2) 1 (3.4) 0 <0.0001
Current smoking 9 (56.2) 12 (41.4) 2 0.37
Family history of CAD 6 (37.5) 3 (10.3) 0 0.050
Obesity (BMI >30 kg/m2) 4 (25) 4 (13.8) 0 0.43
Fever or recent viral illness 0 22 (75.9) 0 <0.0001
TnI on admission (median, IQR) 1.15, IQR 0.45–17.7 3.5, IQR 0.52–8.75 0.48
Peak CK (U/l) (median, IQR) 1609, IQR 665.5–2880 437, IQR 223–999
Left ventricular ejection fraction (%)
(mean±SD)
51±7.5 52.7±8.2
Echocardiogram performed 16 (100) 29 (100) 4
Regional wall motion abnormality
(on echocardiogram)
12 (85.7) 8 (27.6) 0.0042
Total exams performed (coronary
angiogram and/or CMR)
16 23 1
Coronary angiogram alone 12 3 0
CMR alone 0 14 1
CMR and coronary angiogram 4 6 0
All values presented as N (%) unless otherwise stated.
BMI, body mass index; CAD, coronary artery disease; CMR, cardiac MRI.
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Typical subepicardial LGE was found in the majority
of patients with suspected myocarditis. Our series shows
that early CMR is a valuable diagnostic tool to conﬁrm
the diagnosis of myocarditis with a high sensitivity in the
ﬁrst 2 weeks after symptom onset, in accordance with
another recent study.15
The presence of a segmental abnormality on echocar-
diography is very frequent in patient with MI (85.7%)
and signiﬁcantly associated with MI. Nevertheless, seg-
mental abnormality is also found in about one of four
patients with myocarditis, limiting its usefulness in daily
practice to discriminate both diagnoses.
STEMI may occur at any age and should not be over-
looked. All patients <40 years presenting with CP and
typical ST elevation should undergo emergency coronary
angiography, whatever their age or risk factor proﬁle.26
In the absence of typical ST elevation, a thorough evalu-
ation of risk factors (especially diabetes, dyslipidaemia
and family history of CAD) and clinical presentation
(fever or recent symptoms of viral illness) is mandatory.
Some conditions which increase the risk of MI should
be considered in the risk assessment of the young
patient. ‘Red ﬂags’ include recent pregnancy (risk of
coronary dissection), immunological diseases, prior
Takayasu’s arteritis, cocaine abuse, known congenital
coronary abnormality, Churg-Strauss disease, Marfan
disease and known coagulation disorders22 27–33 and
should increase the suspicion of an MI.
Limitations
Our study had a retrospective design, and important
information may have been missing from the charts; for
example, not all patients included had a strict screening
of diabetes (either repetitive glucose blood sampling or
HbA1c dosage), potentially underestimating the number
of patients with diabetes. This study included patients
from a single centre, resulting in a small number of
patients. Our observations will need conﬁrmation from
a larger prospective study. About one-third of patients
with CP assessed in the ED had a TnI test performed.
However, none of the 49 patients included in the study
were previously admitted to our tertiary hospital for CP,
limiting the number of potential previously missed diag-
noses. The deﬁnitive diagnosis of myocarditis remains a
difﬁcult diagnostic challenge and was mostly diagnosed
by CMR in our study. EMB is still considered as the gold
standard for the diagnosis of myocarditis but was only
performed in one of our patients, appropriate to the
current guidelines’ indications.12
CONCLUSION
In conclusion, MI is found in 32.7% of young patients
admitted to the ED with CP and elevated serum cardiac
TnI concentration. MI should therefore not be over-
looked in this population. Several clinical factors may
assist clinicians in differentiating patients with MI from
those with myocarditis. Prospective validation of these
preliminary data in a larger cohort is needed to conﬁrm
these ﬁndings.
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